» Articles » PMID: 29069747

Renal Cell Carcinoma Histological Subtype Distribution Differs by Age, Gender, and Tumor Size in Coastal Chinese Patients

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Oct 27
PMID 29069747
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The distribution pattern of renal cell carcinoma (RCC) histological subtypes according to age, gender and tumor size has not been well illustrated in RCC patients living in fast-developing regions of China. We recruited 2941 patients with clear cell renal cell carcinoma (ccRCC), papillary renal cell carcinoma (PCC) or chromophobe from two hospitals in coastal China (2004-2012) consecutively and draw 538 American Chinese RCC patients' data with time matched from the Surveillance, Epidemiology, and End Results database. We found that compared with ccRCC patients, chromophobe patients were more likely to be female (OR: 2.538, 95% CI: 1.923-3.350), younger (OR for 51-60 years old: 0.686; OR for over 60 years old: 0.478; reference: age < 50) and to have a larger maximal diameter (Dmax) (OR for Dmax > 7 cm: 1.883; reference: Dmax ≤ 4 cm). Besides, in comparison with coastal Chinese patients, American Chinese individuals had lower Fuhrman grades ( < 0.001) and had an onset age 10 years delay. In conclusion, we were the first to observe marked gender, age and tumor size differences in the proportional subtype distribution of RCCs in coastal Chinese patients, and also the first to compare coastal Chinese with American Chinese data.

Citing Articles

Epidemiology and Treatment Outcomes of Renal Cell Carcinoma in Qassim Region, Saudi Arabia: A Retrospective Study.

Alharbi B, Alnosayan H, Al-Harbi F, Alaidah A, Almoshiqeh A, Alharbi A Cureus. 2024; 16(10):e72748.

PMID: 39618569 PMC: 11607626. DOI: 10.7759/cureus.72748.


Molecular differences in renal cell carcinoma between males and females.

Pallauf M, Ged Y, Singla N World J Urol. 2023; 41(7):1727-1739.

PMID: 36905442 DOI: 10.1007/s00345-023-04347-6.


Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma.

Li S, Zhu J, He Z, Ashok R, Xue N, Liu Z Front Oncol. 2022; 12:982833.

PMID: 36452499 PMC: 9701834. DOI: 10.3389/fonc.2022.982833.


A Web-Based Prediction Model for Cancer-Specific Survival of Middle-Aged Patients With Non-metastatic Renal Cell Carcinoma: A Population-Based Study.

Tang J, Wang J, Pan X, Liu X, Zhao B Front Public Health. 2022; 10:822808.

PMID: 35284377 PMC: 8907592. DOI: 10.3389/fpubh.2022.822808.


Hsa_circ_0065217 promotes growth and metastasis of renal cancer through regulating the miR-214-3p-ALPK2 axis.

Yan J, Chen Q, Li Y, Gao Y Cell Cycle. 2021; 20(23):2519-2530.

PMID: 34705617 PMC: 8794523. DOI: 10.1080/15384101.2021.1991123.


References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Bai T, Wang L, Wang D, Yuan X, Bai W, Yang Q . Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014. PLoS One. 2015; 10(12):e0144246. PMC: 4669184. DOI: 10.1371/journal.pone.0144246. View

3.
Lipworth L, Tarone R, McLaughlin J . Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer. 2011; 11:133. PMC: 3087713. DOI: 10.1186/1471-2407-11-133. View

4.
Qi P, Tsivian M, Abern M, Passoni N, McGinley K, Polascik T . Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans. Urol Oncol. 2014; 32(5):555-60. DOI: 10.1016/j.urolonc.2013.11.011. View

5.
Tomlinson I, Alam N, Rowan A, Barclay E, Jaeger E, Kelsell D . Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002; 30(4):406-10. DOI: 10.1038/ng849. View